SCHEMBL14295286

SCHEMBL14295286

c1ccc2c(N(c3ccc(-c4ccc(-c5ccc(N(c6ccc7c(c6)oc6ccccc67)c6cccc7ccccc67)cc5)cc4)cc3)c3ccc4c(c3)oc3ccccc34)cccc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AHR P35869 2/20 0.41
▸ DUSP3 P51452 1/20 0.40
▸ MAPT P10636 4/20 0.40
▸ KMT2A Q03164 4/20 0.40
▸ MEN1 O00255 3/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ HPGD P15428 3/20 0.40
▸ TNKS O95271 1/20 0.35
▸ HCRTR1 O43613 1/20 0.35
▸ PLA2G2A P14555 2/20 0.35
▸ PLA2G4A P47712 2/20 0.35
▸ MMP12 P39900 1/20 0.34
▸ MMP13 P45452 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ MAOA P21397 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6373470 1.00 AHR (0.41) AHRDUSP3MAPTKMT2AMEN1
SCHEMBL15138510 0.97 AHR (0.39) AHRDUSP3MAPTKMT2AMEN1
SCHEMBL14295473 0.96 AHR (0.38) AHRDUSP3MAPTKMT2AMEN1
SCHEMBL14295472 0.96 AHR (0.38) AHRDUSP3MAPTKMT2AMEN1
SCHEMBL14295279 0.96 AHR (0.38) AHRDUSP3MAPTKMT2AMEN1
SCHEMBL15138656 0.95 AHR (0.37) AHRDUSP3MAPTKMT2AMEN1
SCHEMBL14295280 0.95 AHR (0.37) AHRDUSP3MAPTKMT2AMEN1
SCHEMBL18802547 0.95 MAPT (0.37) AHRDUSP3MAPTKMT2AMEN1
SCHEMBL17637178 0.94 AHR (0.45) AHRDUSP3MAPTKMT2AMEN1
SCHEMBL18326954 0.94 CYP1A1 (0.37) AHRDUSP3MAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120319091-A1 AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-12-20 — — US disclosed
US-20120319091-A1 AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-12-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120319091-A1 AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME INMT, TYR, ALKBH2 AHR 147/4885DUSP3 3590/4885MAPT 271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback